New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.
12h
The Brighterside of News on MSNScientists develop microcellular drones to deliver cancer-killing drugsLung cancer is one of the leading causes of cancer mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for about ...
Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seventeen research firms that are currently covering the firm, Marketbeat ...
Detailed price information for Bio-Path Holdings (BPTH-Q) from The Globe and Mail including charting and trades.
Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...
17h
TipRanks on MSNIDEAYA Biosciences Reports 2024 Financials and Business UpdateIdeaya Biosciences ( ($IDYA) ) has released its Q4 earnings. Here is a breakdown of the information Ideaya Biosciences presented to its investors.
You must listen to yourself, sweet Cancer. Changes are brewing in your home or your romantic life at this time. While you’ve been trying to focus on listening to your inner voice, that will ...
You can’t buy love, dearest Cancer. There may be challenges today related to finances and the life that you’ve been trying to create. This may affect your committed relationship or the home ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results